Good post on "Endocrinology Network" news, summarizing of research and trends regarding T3-based thyroid medication prescriptions for hypothyroidism around the world (not mentioning Canada, though). Fuerst, M. (2019, February 14). Physician–patient interaction may influence prescribing patterns in hypothyroidism | Endocrinology Network. Retrieved February 25, 2019, from http://www.endocrinologynetwork.com/thyroid-disorders/physicianpatient-interaction-may-influence-prescribing-patterns-hypothyroidism Apparently, In the United States, in 2017, “approximately …

Continue reading Endocrinology network news reviews study on T3-based therapy prescribing

Are you a thyroid warrior? Can you speak of years lost to hypo or hyper symptoms -- either your own or a family member's or friend's? Will you speak up for those too fatigued to self-advocate? Will you join the fight? What still holds you back? What motivates you to see change? Thyroid warriors. Some …

Continue reading Thyroid warriors: We speak of years lost

Our thyroid patient campaign's researcher submitted a proposal to speak at the Choosing Wisely national conference in Montreal in May 2019. A second thyroid patient was willing to fund the researcher's trip from Western Canada. A third thyroid patient put the researcher in contact with a thyroid doctor who was willing to support such educational …

Continue reading Choosing Wisely chooses not to hear thyroid patient’s research presentation

On Valentine's Day, we thyroid patients send out a big thank you to our supporters. We need people to lean on, to listen, to support us in hard times.

In the "Dirty Money" series on Netflix, the "Drug Short" episode (1) helped me understand some of the economic forces that may have influenced T3 / Liothyronine price hikes in the UK. It makes me concerned about the future of T3 pricing in Canada too. This episode focuses on Valeant, a Canadian pharmaceutical company that …

Continue reading Dirty Money “Drug Short” episode and thyroid T3 Liothyronine